Skip to main content

Peer Review reports

From: A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the P yridostigmine I n S evere CO vid-19 (PISCO) trial protocol

Original Submission
19 Aug 2020 Submitted Original manuscript
21 Sep 2020 Author responded Author comments - Sergio Fragoso-Saavedra
Resubmission - Version 2
21 Sep 2020 Submitted Manuscript version 2
5 Oct 2020 Author responded Author comments - Sergio Fragoso-Saavedra
Resubmission - Version 3
5 Oct 2020 Submitted Manuscript version 3
Publishing
7 Oct 2020 Editorially accepted
16 Oct 2020 Article published 10.1186/s12879-020-05485-7

You can find further information about peer review here.

Back to article page